Core Insights - The article highlights significant corporate announcements and developments in various companies, focusing on their strategic moves and market positions. Company Developments - Joyoung Co., Ltd. clarifies that it and its subsidiaries are not involved in the food and beverage sectors, emphasizing its focus on small home appliances [2] - Rongbai Technology is set to become the primary supplier of sodium battery cathode materials for CATL, with a commitment from CATL to purchase no less than 60% of its total procurement from Rongbai [2] - Heshun Petroleum's actual controller and related parties plan to transfer 6% of the company's shares [2] - Fudan Microelectronics reports that Guosheng Investment intends to acquire 12.99% of shares from Fuxin Fangao, making it the largest shareholder [2] - Maihe Co., Ltd.'s controlling shareholder and chairman Wang Jinping is under investigation and has been detained [2] - Furi Co., Ltd. states that its new energy division currently has no plans for expansion [2] Mergers and Acquisitions - Heshun Petroleum is planning a cross-border acquisition of control over Kuixin Technology, which focuses on integrated circuit IP and Chiplet product development [3] - Chuangye Huikang is in the process of planning a change in control, with its stock set to resume trading [4] Shareholding Changes - Qianli Technology's shareholder Jianghehui plans to reduce its stake by up to 2% [4] - China Aluminum's director Jiang Tao intends to sell no more than 57,500 shares [4] - Time Space Technology plans to reduce its repurchased shares by up to 290,700 [4] Contracts and Project Wins - Samsung Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 168 million yuan [4] Stock Price Movements - Zhongsheng Pharmaceutical's stock is experiencing volatility due to uncertainties in the clinical trial progress and approval results of its innovative drug projects [4] - True Love Home's major shareholder confirms that there are no asset restructuring plans in the next 12 months [5] Other Notable Events - Haosai reports that the local prosecutor's office has appealed a first-instance judgment, leading to uncertainty regarding the final ruling [3] - Guolian Minsheng has received approval for its stock option market-making business [6] - Huaxia Happiness is undergoing pre-restructuring proceedings as accepted by the Langfang Intermediate Court [6] - Zai Jing Pharmaceutical's injectable ZG006 has received orphan drug designation from the FDA for treating neuroendocrine cancer [6]

Core Viewpoint - Jiuyang Co., Ltd. has clarified its non-involvement in the food and beverage sector amidst stock price fluctuations attributed to the "Hakimi" concept, emphasizing its focus on the small home appliance industry [1] Group 1: Stock Performance - Jiuyang's stock price experienced a cumulative increase of 20.95% over two trading days (November 13 and 14, 2025), leading to a market capitalization growth of over 1.6 billion yuan, reaching 9.286 billion yuan [1] - The stock hit its first trading limit on November 13 due to the popularity of "Hakimi soy milk," followed by another limit-up on November 14 [1] Group 2: Company Clarification - Jiuyang stated that it does not engage in the research, production, or sales of food and beverage products, focusing solely on kitchen small appliances [1] - The company clarified on November 13 that there is no equity relationship with "Jiuyang Soy Milk," which is associated with the recently popular "Hakimi" product [1] - Jiuyang exited its shareholder position in Hangzhou Jiuyang Soybean Products Co., Ltd. in December 2023, confirming no direct equity ties between the two companies [1]

Group 1 - On November 14, Zhongsheng Pharmaceutical (002317) experienced a trading halt, closing at 26 CNY per share, with a total market capitalization of 22.1 billion CNY, and a cumulative increase of over 22% in the last three trading days [1][4] - The company announced on November 16 that it is advancing several Phase III clinical trials for its innovative drugs, including Anglavei granules for treating influenza in children aged 2-11 and Anglavei tablets for adolescents aged 12-17, as well as RAY1225 injection for obesity and type 2 diabetes [4][5] - Anglavei tablets are recognized as the world's first oral drug targeting the PB2 site of RNA polymerase for influenza, noted for their rapid, potent, and low-resistance characteristics, with significant recognition from the international academic community [5] Group 2 - The clinical trial progress, review, and approval outcomes for the innovative drug projects carry certain uncertainties, including the potential for drug approval and subsequent market competition dynamics [4] - Other companies, such as Furui Co., Ltd. (002083), have also issued announcements regarding stock price fluctuations, indicating challenges in their respective sectors, particularly in the lithium battery industry [6][7]

（文章来源：证券日报） 证券日报网讯 11月16日晚间，九阳股份发布公告称，公司股票连续两个交易日内日收盘价格涨幅偏离 值累计达到20.95%，属于股票交易异常波动情形。经核查，公司前期披露的信息不存在需要更正、补 充之处；近期公司经营情况正常，内外部经营环境未发生重大变化；公司控股股东及实际控制人不存在 关于本公司的应披露而未披露的重大事项。公司不存在违反信息公平披露的情形。 ...

Investment Rating - The report assigns an "Outperform" rating to multiple companies including Pop Mart, Anta Sports, and Haidilao, while Budweiser Asia is rated "Neutral" [1]. Core Insights - The report highlights significant developments in the food and beverage sector, including Luckin Coffee's preparation for relisting in the U.S. and the launch of new store formats by Jiumaojiu Group's hot pot brand [5][6]. - The retail sales data for October shows a total retail sales figure of 46,291 billion yuan, with a year-on-year growth of 2.9%, indicating a slight recovery in consumer spending [5]. Summary by Sections Company Ratings - Key companies rated "Outperform" include: - Pop Mart - Anta Sports - Haidilao - China Feihe - New Oriental Online - Others [1]. Weekly Performance - Top performers in the food and beverage sector include: - Auntea Jenny (+31.4%) - Haidilao (+7.0%) - Underperformers include: - Xiabuxiabu (-13.1%) [2][6]. Industry News - Notable industry news includes: - Luckin Coffee's plans for a U.S. relisting - Sony's production of a Labubu-themed movie - Jiumaojiu Group's new hot pot store opening - Xiabuxiabu's marketing activities leading to a 45% increase in repeat visits from existing members in certain cities [5][6].

Group 1 - Rongbai Technology signed a cooperation agreement with CATL, becoming its primary supplier of sodium battery cathode materials, with a commitment to supply at least 60% of CATL's total procurement volume if annual purchases exceed 500,000 tons [3] - Meihe Co., Ltd.'s controlling shareholder and chairman Wang Jinping is under investigation and has been placed under detention, with the general manager Zhang Kaixu taking over the chairman's responsibilities [4] - Fudan Microelectronics announced that Guosheng Investment plans to acquire 12.99% of its shares from Fuxin Fangao, making Guosheng the largest shareholder post-transfer [5] Group 2 - Guolian Minsheng received approval from the China Securities Regulatory Commission for its stock option market-making business [6] - Luoping Zinc Electric's subsidiary has received approval to resume production at the Jinpo lead-zinc mine, having met safety and operational requirements [7] - Heshun Petroleum's actual controller and associates plan to transfer 6% of the company's shares through an agreement, maintaining control post-transfer [8] Group 3 - Furi Co., Ltd. stated that there are currently no expansion plans for its new energy sector, amid stock price volatility and potential irrational speculation [9] - Joyoung Co., Ltd. clarified that it operates in the small home appliance sector and does not engage in food and beverage product development or sales [10] - Huaxia Happiness reported abnormal stock trading but confirmed no undisclosed significant matters aside from its pre-restructuring announcement [11] Group 4 - Zhongsheng Pharmaceutical is advancing several clinical trials for its innovative drugs, but the outcomes remain uncertain [12] - Pingtan Development noted that its stock price has risen sharply without significant changes in fundamentals, indicating potential market overreaction [13] Group 5 - Chahua Co., Ltd. announced that a major shareholder plans to reduce its stake by up to 3% within three months [14] - Qianli Technology's major shareholder intends to reduce its stake by up to 2% through a private placement [15] - Gaoling Information's shareholders plan to collectively reduce their holdings by up to 1.5% due to funding needs [16] Group 6 - Guochuang High-tech's major shareholder plans to reduce its stake by up to 1% within three months [17] - China Aluminum's director plans to reduce his stake by a minimal amount of 0.00034% due to personal funding needs [18] - Shikong Technology plans to reduce up to 0.29% of its repurchased shares [19] Group 7 - Xinong Co., Ltd.'s vice president plans to reduce his stake by up to 0.1925% due to personal funding needs [20] - Yifeng Pharmacy's vice presidents plan to collectively reduce their holdings by up to 213,900 shares [21] Group 8 - Samsung Medical's subsidiary is expected to win a procurement project from the State Grid, with an estimated total bid amount of approximately 168.12 million yuan [22]

Key Points - Rongbai Technology has signed a cooperation agreement with CATL, becoming its primary supplier of sodium battery cathode materials, with a commitment to supply at least 60% of CATL's total procurement volume if certain conditions are met [4] - Maihe Co.'s chairman and actual controller has been placed under investigation, with the general manager taking over the chairman's responsibilities [5] - Fudan Microelectronics will see Guosheng Investment become its largest shareholder after acquiring 12.99% of its shares [6][7] - Guolian Minsheng has received approval for stock option market-making business from the China Securities Regulatory Commission [8] - Luoping Zinc & Electric's subsidiary has received approval to resume production at its lead-zinc mine [9] - Heshun Petroleum's actual controller plans to transfer 6% of the company's shares through an agreement, with no change in control expected [10] - Furi Co. has stated that it currently has no plans for capacity expansion despite stock price fluctuations [11] - Joyoung Co. clarified that it operates in the small home appliance sector and does not engage in food and beverage production [12] - Huaxia Happiness reported abnormal stock trading but confirmed no undisclosed major events aside from a pre-restructuring notice [13] - Zhongsheng Pharmaceutical is advancing several clinical trials, but the outcomes remain uncertain [14] - Pingtan Development noted that its stock price has risen sharply without significant changes in fundamentals, indicating potential market overreaction [15] Shareholding Changes - Chahua Co.'s major shareholder plans to reduce its stake by up to 3% [16] - Qianli Technology's shareholder intends to reduce its stake by up to 2% [17] - Gaoling Information's shareholders plan to collectively reduce their stake by up to 1.5% [18] - Guochuang High-tech's major shareholder plans to reduce its stake by up to 1% [19] - China Aluminum's director plans to reduce a very small percentage of shares [20] - Shikong Technology plans to reduce up to 0.29% of its repurchased shares [21] - Xinong Co.'s director plans to reduce up to 0.1925% of shares [22] - Yifeng Pharmacy's vice presidents plan to reduce a total of 213,900 shares [23] Major Contracts - Samsung Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 168.12 million yuan [24]

Core Viewpoint - Jiuyang Co., Ltd. clarifies its non-involvement in the "Haqimi" concept and emphasizes its focus on the small home appliance industry [1] Group 1: Company Overview - Jiuyang Co., Ltd. operates in the small home appliance sector and does not engage in the research, production, or sales of food and beverage products [1] - The company previously held a 25.5001% stake in Hangzhou Jiuyang Bean Products Co., Ltd., which was fully transferred on October 31, 2023, to a new company controlled by founder Wang Xuning [1] Group 2: Market Reaction - The launch of "Haqimi North and South Mung Bean Milk" by Hangzhou Jiuyang Bean Products has gained significant attention due to its association with a popular internet song, leading to increased consumer interest [1] - Following the surge in popularity of the new product, Jiuyang Co., Ltd. experienced a stock price increase, reaching the daily limit on November 13, 2023, and trending on Weibo [1]

Group 1 - Rongbai Technology signed a cooperation agreement with CATL, making Rongbai the primary supplier of sodium battery cathode powder, with a commitment to purchase at least 60% of its total procurement volume annually, potentially reaching 500,000 tons [3] - Meihe Co.'s controlling shareholder and chairman Wang Jinping is under investigation and has been placed under detention, with the general manager Zhang Kaixu taking over the chairman's responsibilities [4] - Fudan Microelectronics announced that Guosheng Investment plans to acquire 12.99% of its shares from Fuxin Fangao, making Guosheng the largest shareholder post-transfer [5] Group 2 - Guolian Minsheng received approval for stock option market-making business from the China Securities Regulatory Commission [6] - Luoping Zinc Electric's subsidiary has received approval to resume production at the Jinpo lead-zinc mine, having met safety and operational requirements [7] - Heshun Petroleum's actual controller and associates plan to transfer 6% of the company's shares through an agreement, maintaining control post-transfer [8] Group 3 - Furi Co. stated that there are currently no expansion plans for its new energy sector, amid stock price volatility and potential irrational speculation [9] - Joyoung Co. clarified that it operates in the small home appliance sector and does not engage in food and beverage production, despite recent market speculation [10][11] - Huaxia Happiness reported abnormal stock trading but confirmed no undisclosed significant matters aside from its pre-restructuring announcement [12] Group 4 - Zhongsheng Pharmaceutical is advancing several clinical trials for its innovative drugs, but the outcomes remain uncertain, including the approval and market competition for its products [13] - Pingtan Development noted that its stock price has risen sharply without significant changes in fundamentals, indicating potential market overreaction [14] Group 5 - Chahua Co. announced that its major shareholder plans to reduce its stake by up to 3% within three months [16] - Qianli Technology's major shareholder intends to reduce its stake by up to 2% through a targeted sale [17] - Gaoling Information's shareholders plan to collectively reduce their holdings by up to 1.5% due to funding needs [18] Group 6 - Guochuang High-tech's major shareholder plans to reduce its stake by up to 1% within three months [19][20] - China Aluminum's director plans to sell a minimal stake of 0.00034% due to personal funding needs [21] - Shikong Technology plans to reduce its repurchased shares by up to 0.29% [22] Group 7 - Xinong Co.'s director plans to reduce his stake by up to 0.1925% due to personal funding needs [23] - Yifeng Pharmacy's vice presidents plan to collectively reduce their holdings by up to 213,900 shares due to personal funding needs [24] Group 8 - Samsung Medical's subsidiary is expected to win a procurement project from the State Grid, with an estimated total bid amount of approximately 168.12 million yuan [26]

编辑 杨娟娟 新京报贝壳财经讯 11月16日，九阳股份发布股票交易异常波动公告，成公司股票交易价格连续两个交 易日内（2025年11月13日、11月14日）日收盘价格涨幅偏离值累计达到20.95%，属于股票交易异常波 动情形。九阳股份方面表示，公司关注到近期市场出现"哈基米"概念的相关报道，公司所属小家电行 业，公司及其下属子公司均不涉及食品、饮料等产品的研发、生产与销售。未来，公司也将继续聚焦深 耕小家电行业。 ...